All In MedTech

Device Trial Radar · NCT04817969

Persona Ti-Nidium Post-Market Clinical Follow-up

Persona® Ti-Nidium® Personalized Total Knee System A Post-Market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data Using the Persona Ti-Nidium Total Knee System and Instrumentation

Last checked: Nov 19, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

240

Planned (sponsor's estimate)

Start

Jun 1, 2021

Primary completion

May 2034

Study completion May 2034

Sponsor

Lead sponsor
Zimmer BiometPublic (ZBH)
Sponsor type
Industry
First posted
Mar 26, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objectives of this study are to evaluate overall clinical performance and safety of the Persona Ti-Nidium implant in total knee arthroplasty.

Conditions

  • Knee Pain Chronic
  • Osteoarthritis
  • Rheumatoid Arthritis
  • Traumatic Arthritis
  • Polyarthritis
  • Varus Deformity
  • Valgus Deformity
  • Flexion Deformity of the Knee
  • Avascular Necrosis
  • Patellofemoral Osteoarthritis

Interventions

  • Zimmer Biomet Persona Ti-Nidium Total Knee SystemDevice

    Primary Knee Total Arthroplasty

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Oxford Knee Score (OKS)Time frame: 10 years

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Denver Hip & Knee, Inc.

    Parker, Colorado

  • MedStar Health Research Institute

    Hyattsville, Maryland

  • Mississippi Sports Medicine and Orthopaedic Center

    Jackson, Mississippi

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.